OCTAGON CAPITAL ADVISORS
Octagon Capital invests in public and private healthcare companies globally. Octagon Capital focuses on strategic long-term investments and strive to work with our portfolio management teams as partners.
OCTAGON CAPITAL ADVISORS
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Apache Global Site Tag
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Rex Health Ventures
Rex Health Ventures is the corporate venture arm of UNC Healthcare and invests in cutting edge healthcare companies.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | Aktis Oncology | Octagon Capital Advisors investment in Series A - Aktis Oncology | 84 M USD |
| 2022-08-16 | Bluejay Therapeutics | Octagon Capital Advisors investment in Series B - Bluejay Therapeutics | 41 M USD |
| 2022-02-15 | ArriVent Biopharma | Octagon Capital Advisors investment in Series A - ArriVent Biopharma | 69 M USD |
| 2021-12-14 | AnHeart Therapeutics | Octagon Capital Advisors investment in Series B - AnHeart Therapeutics | 61 M USD |
| 2021-11-24 | Allorion Therapeutics | Octagon Capital Advisors investment in Series A - Allorion Therapeutics | 40 M USD |
| 2021-11-05 | Edge Medical Robotics | Octagon Capital Advisors investment in Series C - Edge Medical Robotics | 200 M USD |
| 2021-09-13 | Alebund Pharmaceuticals | Octagon Capital Advisors investment in Series B - Alebund Pharmaceuticals | 54.5 M USD |
| 2021-06-30 | ArriVent Biopharma | Octagon Capital Advisors investment in Series A - ArriVent Biopharma | 81 M USD |
| 2021-05-26 | NiKang Therapeutics | Octagon Capital Advisors investment in Series C - NiKang Therapeutics | 200 M USD |
| 2021-05-19 | Numab | Octagon Capital Advisors investment in Series C - Numab | 100 M CHF |
More informations about "Octagon Capital Advisors"
Octagon Capital Advisors - Crunchbase
Octagon Capital Advisors invests in early to late-stage biotechnology and healthcare companies, focusing on therapeutics. Their investment strategy spans Asia and North America, with key locations in Shanghai and the United States. …See details»
Octagon Capital Advisors - Investments, Portfolio & Company Exits
Mar 14, 2021 Octagon Capital invests in public and private healthcare companies globally. Search Crunchbase. ... Octagon Capital Advisors has made 10 diversity investments. Their …See details»
Octagon Capital
Octagon Capital invests in public and private healthcare companies globally. We strive to build long-term investments and partner with our portfolio companies to support innovation. …See details»
Octagon Capital Advisors - LinkedIn
Octagon Capital Advisors | 774 followers on LinkedIn. Octagon Capital invests in public and private healthcare companies globally, with a focus in the US and China. We strive to build long-term ...See details»
Octagon Capital Advisors investment portfolio
Feb 9, 2024 Octagon Capital Advisors General Information Company Description. Founded in 2019, Octagon Capital is a hedge fund manager firm based in New York, New York. The firm seeks to invest in public and private …See details»
Octagon Capital Advisors L.P. 13F annual report - wallmine
As of 8th August 2022, Octagon Capital Advisors L.P.’s top holding is 2,583,059 shares of Apellis Pharmaceuticals Inc currently worth over $117 million and making up 31.2% of the portfolio …See details»
Octagon Capital Advisors Portfolio Companies - Crunchbase
Feb 19, 2016 Octagon Capital invests in public and private healthcare companies globally. This list of organizations invested in by Octagon Capital Advisors provides data on their funding …See details»
Octagon Capital Advisors Fund Manager Profile | Preqin
Octagon Capital Advisors is a New York-based hedge fund manager founded by Dr. Ting Jia. The firm typically invests in securities and financial instruments of companies in the healthcare …See details»
Octagon Capital Advisors LP - 13F
Octagon Capital Advisors LP reported 42 holdings with total value $643 M as of Q3 2024. Top holdings included APLS, I9SA.HA, GPCR, DNTH, and AVBP. Octagon Capital Advisors LP …See details»
Octagon Capital Advisors | MAGNiTT
Octagon Capital invests in public and private healthcare companies globally, with a focus in the US and China. We strive to build long-term investments and partner with our portfolio …See details»
Octagon Capital declared bankrupt; firm suspended
Dec 7, 2015 Toronto-based investment dealer Octagon Capital Corp, has been placed into bankruptcy,and a regulatory hearing panel has suspendedthe firm. ... On Dec. 3, the …See details»
Octagon Capital Advisors - Funding, Financials, Valuation
Octagon Capital Advisors has raised a total of $16.5M in a single venture fund, Octagon Private Opportunities Fund II. This fund was announced on Jul 11, 2022 and raised a total of . …See details»
Mark Koehnlein - Octagon Capital Advisors - LinkedIn
Experience: Octagon Capital Advisors · Education: Saint Michael's College · Location: Darien · 500+ connections on LinkedIn. View Mark Koehnlein’s profile on LinkedIn, a …See details»
Investment Analyst - Octagon Capital Advisors - LinkedIn
Healthcare Investment Analyst at Octagon Capital Advisors · Experience: Octagon Capital Advisors · Education: Harvard University · Location: New York · 500+ connections on LinkedIn. View Hao ...See details»
Octagon Capital - CB Insights
Mar 4, 2024 Octagon Capital Advisors LP lifted its stake in Immunovant by 127.3% in the fourth quarter. Octagon Capital Advisors LP now owns 273,289 shares of the company’s stock …See details»
Former CFO fined, banned after admitting to accounting failures
May 28, 2019 The former CFO of failed investment dealer Octagon Capital Corp. has agreed to a permanent registration ban, after admitting he failed to report the firm’s capital position …See details»
Anran Li, Ph.D. - Octagon Capital Advisors | LinkedIn
Aug 25, 2021 - Passionate about biotech innovation and investment · Experience: Octagon Capital Advisors · Education: Princeton University · Location: New York · 500+ connections on …See details»
Octagon Capital Advisors - Contacts, Employees, Board
Octagon Capital Advisors has 1 current employee profile, Founder and Chief Investment Officer Ting Jia. Contacts. Edit Contacts Section. Job Department. Protected Content. Chief Financial …See details»
Ting Jia - Crunchbase Person Profile
May 18, 2021 Organization Name . Investor Name . Lead Investor . Funding Round . Money Raised . May 9, 2024: ... Ting Jia is the Founder and Chief Investment Officer at Octagon …See details»
Junchen Diao, Ph.D. - Octagon Capital Advisors | LinkedIn
Creative problem solver, life science enthusiast, genuine interest in connecting with… · Experience: Octagon Capital Advisors · Education: The University of Texas MD Anderson Cancer Center ...See details»